Search Results 121-130 of 14775 for anti-TNF drugs

1. Publications - Laura E. Raffals, M.D. - Mayo Clinic

   Anti-TNF biologic therapy does not increase postoperative morbidity in pediatric Crohn's patients. J Pediatr Surg. 2019 Oct; 54 (10):2162-2165 Epub 2019 Jan ...

2. Diclofenac (Topical Application Route) Description and Brand Names - Mayo Clinic

   Diclofenac is a nonsteroidal anti-inflammatory drug (NSAID). Diclofenac topical 3% gel is also used to treat actinic keratosis, a skin problem that may ...

3. Antidepressants: Another weapon against chronic pain - Mayo Clinic

   Medications from other drug classes with distinct mechanisms of pain relief (such as anticonvulsants) may be used in combination with antidepressant class ...

4. Chronic pain: Medication decisions - Mayo Clinic

   Nonsteroidal anti-inflammatory drugs, known as NSAIDs · Acetaminophen · COX-2 inhibitors · Antidepressants and anti-seizure medications · Opioids · Pain medications ...

5. Prednisone and other corticosteroids: Balance the risks and benefits - Mayo Clinic

   Corticosteroid medicines include cortisone, hydrocortisone and prednisone. They are useful in treating rashes, inflammatory bowel disease, asthma and other ...

6. A Phase 2 Study of Anti-PD-L1 Antibody Atezolizumab in Alveolar Soft Part Sarcoma - Mayo Clinic

   ... [anti-TNF] agents) within 2 weeks prior to cycle 1, day 1. Patients who have received acute, low dose, systemic immunosuppressant medications (e.g., a one ...

7. Budesonide (Oral Route) Description and Brand Names - Mayo Clinic

   Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Entocort EC; Eohilia; Ortikos; Uceris ...

8. Updates in interstitial lung disease: Current facets of anti-fibrotic therapy - Mayo Clinic

   Teng Moua, M.D., discusses recent clinical trials and current research into the treatment of idiopathic pulmonary fibrosis (IPF) and non-IPF-progressive ...

9. A Study to Evaluate the Effectiveness and Safety of MEDI2070 in Subjects with Active Moderate to Severe Crohn's Disease - Mayo Clinic

   Prior treatment failure or intolerance with at least one Anti-Tumor Necrosis-Factor-Alpha Therapy (anti-TNF α) agent; Effective contraception from screening ...

10. Infliximab-Dyyb (Intravenous Route, Subcutaneous Route) Description and Brand Names - Mayo Clinic

    It is also used as a maintenance treatment for moderate to severe active Crohn's disease and ulcerative colitis after receiving an infliximab medicine given by ...